Your browser doesn't support javascript.
loading
A long-term, open-label study of valbenazine for tardive dyskinesia.
Lindenmayer, Jean-Pierre; Verghese, Cherian; Marder, Stephen R; Burke, Joshua; Jimenez, Roland; Siegert, Scott; Liang, Grace S; O'Brien, Christopher F.
Afiliação
  • Lindenmayer JP; Department of Psychiatry, New York University School of Medicine, New York, New York, USA.
  • Verghese C; Keystone Clinical Studies, LLC, Norristown, Pennsylvania, USA.
  • Marder SR; Section of Psychosis, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California, USA.
  • Burke J; Department of Biostatistics and Data Management, Neurocrine Biosciences, Inc., San Diego, California, USA.
  • Jimenez R; Department of Clinical Programs, Neurocrine Biosciences, Inc., San Diego, California, USA.
  • Siegert S; Department of Medical and Clinical Affairs, Neurocrine Biosciences, Inc., San Diego, California, USA.
  • Liang GS; Department of Medical Affairs, Neurocrine Biosciences, Inc., San Diego, California, USA.
  • O'Brien CF; Neurocrine Biosciences, Inc., San Diego, California, USA.
CNS Spectr ; 26(4): 345-353, 2021 08.
Article em En | MEDLINE | ID: mdl-32419679
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrabenazina / Valina / Inibidores da Captação Adrenérgica / Discinesia Tardia Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrabenazina / Valina / Inibidores da Captação Adrenérgica / Discinesia Tardia Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article